Prognostic Importance of Comorbidity in a Hospital-Based Cancer Registry
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
CONTEXT: Patients with cancer often have other medical ailments, referred to as comorbidity. Comorbidity may impact treatment decision-making, prognosis, and quality of care assessment. OBJECTIVE: To assess whether comorbidity information can provide important prognostic information in a hospital-based cancer registry. DESIGN, SETTING, AND PARTICIPANTS: An observational prospective cohort study using comorbidity data collected by trained hospital-based cancer registrars. Comorbidity was obtained through medical record review using the Adult Comorbidity Evaluation 27, a validated chart-based comorbidity instrument. A total of 17,712 patients receiving care between January 1, 1995, and January 31, 2001, for the primary diagnosis of new cancer of the prostate, lung (nonsmall cell), breast, digestive system, gynecological, urinary system, or head and neck were included. MAIN OUTCOME MEASURE: Duration in months of overall survival. RESULTS: A total of 19,268 patients were included in the study; median duration of follow-up was 31 months. Of these patients, 1556 (8.0%) were excluded due to missing or unknown data. Severity of comorbidity strongly influenced survival in a dose-dependent fashion and the impact of comorbidity was independent of cancer stage. Compared with patients without comorbidity, the adjusted hazard ratio associated with mild comorbidity was 1.21 (95% confidence interval [CI], 1.13-1.30), moderate comorbidity was 1.86 (95% CI, 1.73-2.00), and severe comorbidity was 2.56 (95% CI, 2.35-2.81). Adjusted Kaplan-Meier survival curves revealed that at any point in time the patients with more severe levels of comorbidity had worse survival (partial chi2(3) due to comorbidity, 523.54; P<.001). Model discrimination ranged from 0.71 for head and neck to 0.86 for prostate cancers. CONCLUSIONS: Comorbidity is an important independent prognostic factor for patients with cancer. The inclusion of comorbidity in hospital-based cancer registries will increase the value and use of observational research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Comorbidity measures for use with administrative data.
Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998) · Medical Care · doi:10.1097/00005650-199801000-00004 · Cited by 9,921
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Development of a comorbidity index using physician claims data
Klabunde, C. N., Potosky, A. L., Legler, J. M., & Warren, J. L. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00256-0 · Cited by 1,845
The pre-therapeutic classification of co-morbidity in chronic disease
Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544 · cited 1×
“These conditions and diseases, which exist before cancer diagnosis and are not adverse effects of cancer treatment, are generally referred to as comorbidities.(2) While a routine consideration in selecting treatment and clinical decisionmaking, comorbidity is generally not considered in the design of cancer data sets…”
BackgroundRisk Adjustment for Measuring Healthcare Outcomes
Iezzoni, L. I. (1994) · Cited by 955
Effect of Age and Comorbidity in Postmenopausal Breast Cancer Patients Aged 55 Years and Older
Yancik, R. (2001) · JAMA · doi:10.1001/jama.285.7.885 · Cited by 896
The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer
Satariano, W. A., & Ragland, D. R. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-2-199401150-00002 · Cited by 731
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus
Kaplan, M. H., & Feinstein, A. R. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90017-4 · Cited by 670
Greenfield, S., Apolone, G., McNeil, B. J., & Cleary, P. D. (1993) · Medical Care · doi:10.1097/00005650-199302000-00005 · Cited by 493
Yancik, R., Wesley, M. N., Ries, L., Havlik, R. J., Long, S., Edwards, B. K., & Yates, J. W. (1998) · PubMed · Cited by 408
lezzoni, L. I. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550190064046 · Cited by 408
Importance of Comorbidity in Head and Neck Cancer
Piccirillo, J. F. (2000) · The Laryngoscope · doi:10.1097/00005537-200004000-00011 · Cited by 398
Self-citationMeasurement and impact of comorbidity in older cancer patients
Extermann, M. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00090-1 · Cited by 299
Perspectives on Comorbidity and Cancer in Older Patients: Approaches to Expand the Knowledge Base
Yancik, R., Ganz, P. A., Varricchio, C. G., & Conley, B. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1147 · Cited by 284
Clinical symptoms and comorbidity: significance for the prognostic classification of cancer
Piccirillo, J. F., & Feinstein, A. R. (1996) · Cancer · Cited by 240
Self-citationThe Impact of Co-morbidity on Life Expectancy Among Men with Localized Prostate Cancer
Albertsen, P. C., Fryback, D. G., Storer, B. E., Kolon, T. F., & Fine, J. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)65964-0 · Cited by 238
Kieszak, S. M., Flanders, W. D., Kosinski, A. S., Shipp, C. C., & Karp, H. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00154-1 · Cited by 218
Using administrative data to describe casemix: A comparison with the medical record
Malenka, D. J., McLerran, D., Roos, N., Fisher, E. S., & E.Wennberg, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90118-x · Cited by 166
The Effect of Age and Comorbidity in the Treatment of Elderly Women With Nonmetastatic Breast Cancer
Newschaffer, C. J. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.1.85 · Cited by 165
New Clinical Severity Staging System for Cancer of the Larynx
Piccirillo, J. F., Sasaki, C. T., Wells, C. K., & Feinstein, A. R. (1994) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348949410300201 · Cited by 134
Self-citationThe Impact Of Co-morbid Disease on Cancer Control and Survival Following Radical Cystectomy
MILLER, D. C., Taub, D. A., Dunn, R. L., Montie, J. E., & Wei, J. (2003) · The Journal of Urology · doi:10.1016/s0022-5347(05)64046-3 · Cited by 130
Fleming, S. T., Rastogi, A., Dmitrienko, A. A., & Johnson, K. D. (1999) · Medical Care · doi:10.1097/00005650-199906000-00009 · Cited by 119
Hall, S. F., Groome, P. A., & Rothwell, D. M. (2000) · Head & Neck · Cited by 115
Factors that Determine the Treatment for Local and Regional Prostate Cancer
Desch, C. E., Penberthy, L., Newschaffer, C. J., Hillner, B. E., Whittemore, M., McClish, D. K., Smith, T. J., & Retchin, S. M. (1996) · Medical Care · doi:10.1097/00005650-199602000-00007 · Cited by 107
A Decision Analysis for Treatment of Clinically Localized Prostate Cancer
Kattan, M. W., Cowen, M. E., & Miles, B. J. (1997) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1997.012005299.x · Cited by 102
Inclusion of comorbidity in a staging system for head and neck cancer.
Piccirillo, J. F. (1995) · PubMed · Cited by 65
Self-citationHarrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
Cited by
Sorror, M. L., Maris, M. B., Storb, R., Baron, F., Sandmaier, B. M., Maloney, D. G., & Storer, B. (2005) · Blood · doi:10.1182/blood-2005-05-2004 · Cited by 2,969
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
Davis, I. D., Martin, A. J., Stockler, M. R., Begbie, S., Chi, K. N., Chowdhury, S., Coskinas, X., Frydenberg, M., Hague, W. E., Horvath, L. G., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903835 · Cited by 1,633
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Pfister, D. G., Spencer, S., Adelstein, D., Adkins, D., Anzai, Y., Brizel, D. M., Bruce, J. Y., Busse, P. M., Caudell, J. J., Cmelak, A. J., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0031 · Cited by 1,360
Comprehensive geriatric assessment for older patients with cancer
Extermann, M., & Hurria, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.6559 · Cited by 875
Physical activity and survival after colorectal cancer diagnosis
Meyerhardt, J. A., Giovannucci, E. L., Holmes, M. D., Chan, A. T., Chan, J. A., Colditz, G. A., & Fuchs, C. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.0855 · Cited by 857
Metadata
- Authors
- Piccirillo, J. F.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-05-26
- Volume
- 291
- Issue
- 20
- Pages
- 2441
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1997468904
- Cited by
- 1,205
- References
- 28
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.